1,443
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Myocardial angiogenesis induced by exercise training involves a regulatory mechanism mediated by kinin receptors

, , , , , & show all
Pages 408-415 | Received 25 Nov 2020, Accepted 17 Feb 2021, Published online: 09 Mar 2021

References

  • Bekhite MM, Finkensieper A, Binas S, Muller J, Wetzker R, Figulla HR, Sauer H, Wartenberg M. 2011. VEGF-mediated PI3K class IA and PKC signaling in cardiomyogenesis and vasculogenesis of mouse embryonic stem cells. J Cell Sci. 124(Pt11):1819–30. doi:10.1242/jcs.077594.
  • Iemitsu M, Maeda S, Jesmin S, Otsuki T, Miyauchi T. 2006. Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts. Am J Physiol Heart Circ Physiol. 291(3):H1290–1298. doi:10.1152/ajpheart.00820.2005.
  • Koch S, Claesson-Welsh L. 2012. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med. 2(7):a006502. doi:10.1101/cshperspect.a006502.
  • Prior BM, Yang HT, Terjung RL. 2004. What makes vessels grow with exercise training? J Appl Physiol (1985). 97(3):1119–28. doi:10.1152/japplphysiol.00035.2004.
  • Lee PC, Salyapongse AN, Bragdon GA, Shears LL 2nd, Watkins SC, Edington HD, Billiar TR.Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol. 1999;277(4):H1600–1608. doi:10.1152/ajpheart.1999.277.4.H1600.
  • Sanchez De Miguel L, Neysari S, Jakob S, Petrimpol M, Butz N, Banfi A, Zaugg CE, Humar R, Battegay EJ. 2008. B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart. Cardiovasc Res. 80(1):106–13. doi:10.1093/cvr/cvn170.
  • Couture R, Harrisson M, Vianna RM, Cloutier F. 2001. Kinin receptors in pain and inflammation. Eur J Pharmacol. 429(1–3):161–76. doi:10.1016/s0014-2999(01)01318-8.
  • Avgeris M, Mavridis K, Scorilas A. 2010. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies. Biol Chem. 391(5):505–11. doi:10.1515/BC.2010.056.
  • Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. 2005. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 99(1):6–38. doi:10.1254/jphs.srj05001x.
  • Yin H, Chao L, Chao J. 2005. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J Biol Chem. 280(9):8022–30. doi:10.1074/jbc.M407179200.
  • Griol-Charhbili V, Messadi-Laribi E, Bascands JL, Heudes D, Meneton P, Giudicelli JF, Alhenc-Gelas F, Richer C. 2005. Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia. Faseb J. 19(9):1172–74. doi:10.1096/fj.04-3508fje.
  • Moraes MR, Bacurau RF, Ramalho JD, Reis FC, Casarini DE, Chagas JR, Oliveira V, Higa EM, Abdalla DS, Pesquero JL, et al. Increase in kinins on post-exercise hypotension in normotensive and hypertensive volunteers. Biol Chem. 2007;388(5):533–40. doi:10.1515/BC.2007.055.
  • Mombouli JV, Vanhoutte PM. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1995;35:679–705. doi:10.1146/annurev.pa.35.040195.003335.
  • Deacon K, Knox AJ. 2015. Human airway smooth muscle cells secrete amphiregulin via bradykinin/COX-2/PGE2, inducing COX-2, CXCL8, and VEGF expression in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 309(3):L237–249. doi:10.1152/ajplung.00390.2014.
  • Donnini S, Solito R, Giachetti A, Granger HJ, Ziche M, Morbidelli L. 2006. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium. J Pharmacol Exp Ther. 319(2):515–22. doi:10.1124/jpet.106.108803.
  • Li P, Kondo T, Numaguchi Y, Kobayashi K, Aoki M, Inoue N, Okumura K, Murohara T. 2008. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis. Hypertension. 51(2):252–58. doi:10.1161/HYPERTENSIONAHA.107.097394.
  • Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis MB, Straino S, Tozzi MG, Smith R, Gaspa L, et al. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation. 2001;103(1):125–32. doi:10.1161/01.cir.103.1.125.
  • Cui M, Dong Q, Tang M, Ren HM. 2007. The Neuroprotective effect of bradykinin receptor antagonists in cerebral ischemia/reperfusion rats. Chin J Neuroanatomy. 40(1–2):1–6. doi:10.1109/WISP.2007.4447538.
  • Bedford TG, Tipton CM, Wilson NC, Oppliger RA, Gisolfi CV. 1979. Maximum oxygen consumption of rats and its changes with various experimental procedures. J Appl Physiol Respir Environ Exerc Physiol. 47(6):1278–83. doi:10.1152/jappl.1979.47.6.1278.
  • Pontes FL Jr., Bacurau RF, Moraes MR, Navarro F, Casarini DE, Pesquero JL, Pesquero JB, Araujo RC, Picarro IC. 2008. Kallikrein kinin system activation in post-exercise hypotension in water running of hypertensive volunteers. Int Immunopharmacol. 8(2):261–66. doi:10.1016/j.intimp.2007.09.001.
  • Shen M, Yu M, Li J, Ma L. 2017. Effects of exercise training on kinin receptors expression in rats with myocardial infarction. Arch Physiol Biochem. 123(4):206–11. doi:10.1080/13813455.2017.1302962.
  • Yu HS, Wang SW, Chang AC, Tai HC, Yeh HI, Lin YM, Tang CH. 2014. Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells. Biochem Pharmacol. 87(2):243–53. doi:10.1016/j.bcp.2013.10.016.
  • Munk VC, Sanchez De Miguel L, Petrimpol M, Butz N, Banfi A, Eriksson U, Hein L, Humar R, Battegay EJ. 2007. Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway. Hypertension. 49(5):1178–85. doi:10.1161/HYPERTENSIONAHA.106.080242.
  • Gao L, Yu DM.Molecular mechanism of limbs’ postischemic revascularization improved by perindopril in diabetic rats. Chin Med J (Engl). 2008;121(21):2129–33. doi:10.1097/00029330-200811010-00004.
  • Bellafiore M, Battaglia G, Bianco A, Palma A. Expression pattern of angiogenic factors in healthy heart in response to physical exercise intensity. Front Physiol. 2019;10:238. doi:10.3389/fphys.2019.00238.
  • Emanueli C, Bonaria Salis M, Stacca T, Pintus G, Kirchmair R, Isner JM, Pinna A, Gaspa L, Regoli D, Cayla C, et al. Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation. 2002;105(3):360–66. doi:10.1161/hc0302.102142.
  • Morbidelli L, Parenti A, Giovannelli L, Granger HJ, Ledda F, Ziche M. 1998. B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br J Pharmacol. 124(6):1286–92. doi:10.1038/sj.bjp.0701943.
  • Krankel N, Katare RG, Siragusa M, Barcelos LS, Campagnolo P, Mangialardi G, Fortunato O, Spinetti G, Tran N, Zacharowski K, et al. Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res. 2008;103(11):1335–43. doi:10.1161/CIRCRESAHA.108.179952.
  • Valdes G, Schneider D, Corthorn J, Ortiz R. 2012. OS059. Blockade of the bradykinin B2 receptor in early pregnancy reduces fetal growth and trophoblast invasion in guinea-pigs. Pregnancy Hypertens. 2(3):208–09. doi:10.1016/j.preghy.2012.04.060.
  • Soufi FG, Farajnia S, Aslanabadi N, Ahmadiasl N, Alipour M, Alipour M, Doustar Y, Abdolalizadeh J, Sheikhzadeh F.Long-term exercise training affects age-induced changes in HSP70 and apoptosis in rat heart. Gen Physiol Biophys. 2008;27(4):263–70.
  • Yoshida H, Zhang JJ, Chao L, Chao J. 2000. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension. 35(1 Pt 1):25–31. doi:10.1161/01.hyp.35.1.25.
  • Yao YY, Yin H, Shen B, Chao L, Chao J. 2007. Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regul Pept. 140(1–2):12–20. doi:10.1016/j.regpep.2006.11.020.